[go: up one dir, main page]

NO20082263L - Organiske forbindelser - Google Patents

Organiske forbindelser

Info

Publication number
NO20082263L
NO20082263L NO20082263A NO20082263A NO20082263L NO 20082263 L NO20082263 L NO 20082263L NO 20082263 A NO20082263 A NO 20082263A NO 20082263 A NO20082263 A NO 20082263A NO 20082263 L NO20082263 L NO 20082263L
Authority
NO
Norway
Prior art keywords
compounds
preparation
aliskiren
salt
compound
Prior art date
Application number
NO20082263A
Other languages
English (en)
Other versions
NO342854B1 (no
Inventor
Gottfried Sedelmeier
Dominique Grimler
Murat Acemoglu
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35451886&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20082263(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20082263L publication Critical patent/NO20082263L/no
Publication of NO342854B1 publication Critical patent/NO342854B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Foreliggende oppfinnelse angår en ny fremgangsmåte, nye fremgangsmåtetrinn og nye intermediater anvendelige ved syntese av farmasøytisk aktive forbindelser, særlig renininhibitorer, slik som aliskiren. Blant annet angår oppfinnelsen en fremgangsmåte for fremstilling av en forbindelse med formel II, eller et salt derav, og en forbindelse med formel VI eller et salt derav, hvori R3 og R4 så vel som Act er som definert i beskrivelsen, og fremgangsmåter for fremstilling av disse. Ytterligere omdanning av forbindelser (VI) med metallo-organiske forbindelser (VII) gir opphav til nye forbindelser (VMI) som er direkte forløpere for fremstilling av aliskiren.
NO20082263A 2005-10-17 2008-05-16 Intermediater ved syntese av renininhibitorer, og fremgangsmåte for fremstilling derav. NO342854B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0521083.6A GB0521083D0 (en) 2005-10-17 2005-10-17 Organic compounds
PCT/EP2006/009970 WO2007045420A2 (en) 2005-10-17 2006-10-16 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors

Publications (2)

Publication Number Publication Date
NO20082263L true NO20082263L (no) 2008-07-07
NO342854B1 NO342854B1 (no) 2018-08-20

Family

ID=35451886

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082263A NO342854B1 (no) 2005-10-17 2008-05-16 Intermediater ved syntese av renininhibitorer, og fremgangsmåte for fremstilling derav.

Country Status (29)

Country Link
US (2) US7772405B2 (no)
EP (1) EP1948643B1 (no)
JP (3) JP5356031B2 (no)
KR (1) KR101294432B1 (no)
CN (2) CN101111493B (no)
AR (1) AR058089A1 (no)
AU (1) AU2006303489B2 (no)
BR (1) BRPI0617492A2 (no)
CA (2) CA2829487A1 (no)
CY (1) CY1114308T1 (no)
DK (1) DK1948643T3 (no)
EC (1) ECSP088368A (no)
ES (1) ES2427098T3 (no)
GB (1) GB0521083D0 (no)
HR (1) HRP20130793T1 (no)
IL (1) IL190330A (no)
JO (1) JO2926B1 (no)
MY (1) MY145466A (no)
NO (1) NO342854B1 (no)
NZ (1) NZ567042A (no)
PE (2) PE20120581A1 (no)
PL (1) PL1948643T3 (no)
PT (1) PT1948643E (no)
RU (1) RU2432354C2 (no)
SI (1) SI1948643T1 (no)
TN (1) TNSN08170A1 (no)
TW (1) TWI395733B (no)
WO (1) WO2007045420A2 (no)
ZA (1) ZA200802632B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds
DE102005052195A1 (de) * 2005-10-28 2007-05-03 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von chiralen Octensäurederivaten
US8338620B2 (en) * 2007-04-03 2012-12-25 Novartis Ag Methods for the production of C-8 lactam lactone compounds
AU2008265181A1 (en) * 2007-06-19 2008-12-24 Novartis Ag Process for the synthesis of intermediates of renin inhibitors such as aliskiren
DE102007049039A1 (de) * 2007-10-11 2009-04-16 Reuter Chemischer Apparatebau Kg Verfahren zur Herstellung von 8-Hydrazino-8-Aryl-Octanoylderivaten und deren Verwendung
SI2189442T1 (sl) * 2008-11-20 2015-03-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek in intermediati za pripravo aliskirena
JP5746696B2 (ja) * 2009-08-11 2015-07-08 ノバルティス アーゲー ラクトンおよびラクタムの開環
WO2011051853A1 (en) * 2009-10-29 2011-05-05 CarboDesign LLC Manufacturing process for preparing enaniomerically pure 8- aryloctanoic acid derivatives such as aliskiren
US20110137047A1 (en) * 2009-12-07 2011-06-09 CarboDesign LLC Process for enantiomerically pure 8-Aryloctanoic acids as Aliskiren
CN101774986B (zh) 2010-01-06 2012-03-28 浙江天宇药业股份有限公司 一种制备阿利克伦及其中间体的方法
CN102241650B (zh) * 2010-05-14 2014-05-07 浙江九洲药业股份有限公司 用于制备阿立克仑的中间体化合物及相关制备方法
CN102485722B (zh) * 2010-12-06 2014-05-07 博瑞生物医药技术(苏州)有限公司 阿利克仑、其中间体和药用盐及制备方法
CN102775393B (zh) * 2011-05-09 2014-08-27 上海现代制药股份有限公司 一种药物中间体的制备方法
US8703976B2 (en) 2011-10-02 2014-04-22 Milan Soukup Manufacturing process for 8-aryloctanoic acids such as Aliskiren
CN102746182B (zh) * 2012-07-27 2014-09-03 浙江普洛医药科技有限公司 一种阿利克伦的制备方法
CN103059012B (zh) * 2013-01-30 2016-06-22 浙江海翔药业股份有限公司 1,8-二羰基-4,5-环氧化合物及其制备方法
CN104876832B (zh) * 2014-02-28 2016-12-07 华润双鹤药业股份有限公司 阿利吉仑的4-位差向异构体、其制备方法及用途
CN105294612A (zh) * 2014-06-05 2016-02-03 山东威智医药工业有限公司 阿利克仑中间体及其制备方法和应用
US10087190B1 (en) * 2017-04-24 2018-10-02 Purdue Research Foundation Lactones
CN114315749B (zh) * 2021-12-13 2024-04-26 湖南华腾医药有限公司 一种连续流微反应器合成阿利克仑中间体的方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0678503A1 (de) * 1994-04-18 1995-10-25 Ciba-Geigy Ag Delta-Amino-gamma-hydroxy-omega-aryl-alkansäureamide mit Enzym-, insbesondere Renin-hemmenden Eigenschaften

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5659065A (en) 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) * 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
WO2001009083A1 (de) * 1999-07-29 2001-02-08 Speedel Pharma Ag Herstellung von n-substituierten 2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoylamiden
FR2801051B1 (fr) * 1999-11-17 2001-12-14 Adir Nouveaux composes aminopyrroline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6310904B1 (en) 2000-05-31 2001-10-30 Honeywell International, Inc. Measurement method to facilitate production of self-aligning laser gyroscope block
PT1215201E (pt) 2000-12-14 2007-02-28 Speedel Pharma Ag Processo para a preparação de ariloctanoil amidas
DE50207212D1 (de) * 2001-09-07 2006-07-27 Basf Ag Verfahren zur herstellung von 2-pyrrolidon
GB0212410D0 (en) * 2002-05-29 2002-07-10 Novartis Ag Organic compounds
CN1882528A (zh) * 2003-11-26 2006-12-20 诺瓦提斯公司 有机化合物
SV2005001973A (es) * 2003-12-12 2005-11-04 Wyeth Corp Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500)
WO2005090305A1 (en) * 2004-03-19 2005-09-29 Speedel Experimenta Ag 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
EP1582523A1 (en) * 2004-04-02 2005-10-05 Ludwig-Maximilians-Universität München Method of preparing organomagnesium compounds
GB0419361D0 (en) * 2004-08-31 2004-10-06 Novartis Ag Organic compounds
GB0511686D0 (en) * 2005-06-08 2005-07-13 Novartis Ag Organic compounds
GB0521083D0 (en) * 2005-10-17 2005-11-23 Novartis Ag Organic compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0678503A1 (de) * 1994-04-18 1995-10-25 Ciba-Geigy Ag Delta-Amino-gamma-hydroxy-omega-aryl-alkansäureamide mit Enzym-, insbesondere Renin-hemmenden Eigenschaften

Also Published As

Publication number Publication date
KR20080057285A (ko) 2008-06-24
TWI395733B (zh) 2013-05-11
TW200800965A (en) 2008-01-01
CA2625034A1 (en) 2007-04-26
ZA200802632B (en) 2009-04-29
AU2006303489B2 (en) 2011-04-07
ECSP088368A (es) 2008-05-30
SI1948643T1 (sl) 2013-10-30
CN101111493A (zh) 2008-01-23
AR058089A1 (es) 2008-01-23
KR101294432B1 (ko) 2013-08-07
NZ567042A (en) 2012-02-24
MY145466A (en) 2012-02-15
JP2014196312A (ja) 2014-10-16
AU2006303489A1 (en) 2007-04-26
JP2013032369A (ja) 2013-02-14
JP2009514808A (ja) 2009-04-09
CA2625034C (en) 2014-08-19
US8198465B2 (en) 2012-06-12
IL190330A (en) 2013-12-31
PT1948643E (pt) 2013-09-05
JP5792139B2 (ja) 2015-10-07
CN103121995A (zh) 2013-05-29
JO2926B1 (en) 2015-09-15
GB0521083D0 (en) 2005-11-23
ES2427098T3 (es) 2013-10-28
HK1120509A1 (en) 2009-04-03
JP5356031B2 (ja) 2013-12-04
PE20120581A1 (es) 2012-06-08
CN101111493B (zh) 2013-02-13
WO2007045420A2 (en) 2007-04-26
EP1948643A2 (en) 2008-07-30
RU2008119276A (ru) 2009-11-27
EP1948643B1 (en) 2013-06-05
PL1948643T3 (pl) 2013-11-29
BRPI0617492A2 (pt) 2011-07-26
DK1948643T3 (da) 2013-09-08
US20080262246A1 (en) 2008-10-23
RU2432354C2 (ru) 2011-10-27
WO2007045420A3 (en) 2007-06-07
HRP20130793T1 (hr) 2013-09-30
CN103121995B (zh) 2016-08-03
US20100267965A1 (en) 2010-10-21
PE20070792A1 (es) 2007-09-10
US7772405B2 (en) 2010-08-10
NO342854B1 (no) 2018-08-20
CY1114308T1 (el) 2016-08-31
TNSN08170A1 (en) 2009-10-30
IL190330A0 (en) 2009-09-22
CA2829487A1 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
NO20082263L (no) Organiske forbindelser
NO20076660L (no) Fremgangsmate for fremstilling av rosuvastatin og mellomprodukter
WO2011015522A3 (en) Process for the manufacture of pharmaceutically active compounds
EA201270550A1 (ru) Процесс получения соединений для применения в качестве ингибиторов sglt2
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
WO2006133147A3 (en) Organic compounds
NO20080080L (no) Organiske forbindelser
NO20072872L (no) Kjemisk prosess
TN2009000401A1 (en) New methods
NO20081685L (no) Fremgangsmate for fremstilling oksazolidin-beskyttelse aminodolforbindelser anvendbare som mellomprodukter for Florfenicol
NO20082005L (no) Syntese av renininhibitorer omfattende en cyklotilfoyelsesreaksjon
NO20081621L (no) Tetrahydrokinoliner, syntese og intermediater
WO2008155338A3 (en) Process for the synthesis of intermediates of renin inhibitors such as aliskiren
MX2009004343A (es) Compuestos organicos.
GB0508318D0 (en) Organic compounds
NO20080468L (no) Diazepinokinoliner, synteser av disse samt intermediater
MY144657A (en) Crystalline polymorphs of a cxc-chemokine receptor ligand.
NO20076000L (no) Aminosyrederivater
MX2010009876A (es) Nuevo proceso para la preparacion de derivados de acido ciclohexanocarboxilico por medio del derivado de ciclohexanocarboxamida correspondiente.
WO2008103367A3 (en) Method for assembling high-purity chemical libraries, proapoptotic compounds discovered by same
EA200870038A1 (ru) Способ получения аминов
UA85701C2 (ru) Способ получения ингибиторов триптазы
NO20076307L (no) Fremgangsmater for a fremstille biarylurinstoffer og analoger derav
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
NO20091971L (no) Saltformer av substituerte benzotienylforbindelser

Legal Events

Date Code Title Description
RE Reestablishment of rights (par. 72 patents act)
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: NODEN PHARMACEUTICALS DAC, IE

MM1K Lapsed by not paying the annual fees